2024 STI Prevention Conference: Neisseria Gonorrhea Prevalence and Novel Treatment and Prevention Medications

About this episode

This episode reviews abstracts on antimicrobial-resistant Neisseria Gonorrhea and novel treatment options presented at the 2024 STI Prevention Conference.

This episode reviews five oral abstracts on the prevalence of antimicrobial-resistant Neisseria Gonorrhea globally and in the US; clinical trial results of two novel oral antibiotics; and the protective effect of a meningococcal vaccine. These abstracts were presented at the 2024 STI Prevention Conference. View the abstracts in the 2024 STI Prevention Conference Abstract Book. View episode transcript at www.std.uw.edu. This podcast is dedicated to an STD [sexually transmitted disease] review...

People in this episode

Host: National STD Curriculum

Topics covered

• STI prevention
• Neisseria Gonorrhea
• antimicrobial resistance
• clinical trials
• novel antibiotics
• vaccine efficacy

Keywords

• STI
• Neisseria Gonorrhea
• antimicrobial resistance
• oral antibiotics
• meningococcal vaccine
• clinical trials

Mentioned in this episode

Organizations: Neisseria Gonorrhea, 2024 STI Prevention Conference, meningococcal vaccine

More episodes of National STD Curriculum Podcast

• Recent Research on the Impact of Doxy PEP · May 13, 2026 · 15 min
• Gepotidacin or Zoliflodacin to Treat Gonorrhea · April 17, 2026 · 13 min
• A Globally Emerging Fungus Causing Dermatophytosis · February 27, 2026 · 13 min
• Is Bacterial Vaginosis (BV) an STI? · January 31, 2026 · 15 min
• 2024 STI Prevention Conference: STI Testing and Diagnosis in Adolescents and Young Adults · December 30, 2025 · 12 min
• 2024 STI Prevention Conference: Innovative STI Testing and Management · November 1, 2025 · 17 min